NRX Pharmaceuticals Inc — Balance Sheet (NASDAQ:NRXP) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 32.73 M25.82 M7.32 M3.65 M12.96 M Total liabilities 11.92 M18.41 M19.05 M26.87 M28.89 M Total equity 20.81 M7.41 M-11.73 M-23.22 M-15.94 M Total liabilities & shareholders' equities 32.73 M25.82 M7.32 M3.65 M12.96 M Total debt ——9.16 M6.58 M0 Net debt ——4.57 M5.13 M-7.17 M

News

NRx Pharmaceuticals, Inc. (NRXP) Surpasses Q4 Earnings Estimates

NRx Pharmaceuticals, Inc. (NRXP) Shareholder/Analyst Call Prepared Remarks Transcript

NRx Pharmaceuticals receives FDA bioequivalence approval notice

NRx Pharmaceuticals receives FDA guidance on NRX-100 drug application

VTSAX vs. VTI: Which Vanguard Fund Should You Buy in 2026? - TipRanks.com

H.C. Wainwright raises NRx Pharmaceuticals stock price target to $45

NRx Pharmaceuticals appoints Joshua Brown as chief medical officer

NRx Builds Momentum From FDA Progress To Strategic Expansion - NRX Pharmaceuticals (NASDAQ:NRXP)

Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/23/26 - TipRanks.com

NRx Pharmaceuticals appoints Joseph M. Casper as chief operating officer

New Strong Sell Stocks for January 27th

H.C. Wainwright reiterates Buy rating on NRx Pharmaceuticals stock at $40